Dosage-Escalation Study of the Safety and Immunogenicity of a Novel Rabies Vaccine ChAd155-RG vs. the Comparator RABAVERT Vaccine in Healthy Adult Subjects
Clinical trial NCT04019444 · COMPLETED
Trial details
- NCT number
- NCT04019444
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-19
- Primary completion
- 2023-03-24
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.